The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Cara Edwards

Tel:
Work +1 212 335 4714
Email:
DLA Piper LLP (US)

Work Department

Litigation

Position

Partner

Career

Cara Edwards is a partner in Product Liability and Mass Tort practice group. Cara currently serves on the national coordinating counsel team for all asbestos, talc, silica, and other toxic tort exposure litigation for her clients' nationwide dockets. She manages and collaborates with local counsel across the country to develop national defense strategies, including motion and discovery practice. Her experience also includes defending consumer-related claims in numerous jurisdictions, the development of expert witness reports and testimony, and consulting on strategic planning issues faced by her clients. Cara regularly counsels clients on a wide range of risk management, regulatory, product labeling, recall and public disclosure issues.

Member

American and New York City Bar Associations; DRI (Defense Research Institute); Association of Black Women Attorneys; National Association of Women Lawyers

Education

JD, New York University; BA, Colgate University


United States: Dispute resolution

Product liability, mass tort and class action: pharmaceuticals and medical devices - defense

Within: Next generation lawyers

Cara Edwards - DLA Piper LLP (US)

Within: Product liability, mass tort and class action: pharmaceuticals and medical devices - defense

DLA Piper LLP (US)’s pharmaceutical and medical device practice is jointly headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and handles sector-related product liability litigation and mass torts. Williams and New York-based Loren Brown continue to act as national counsel for Novo Nordisk in all litigation arising from claims alleging that some type 2 diabetes treatments can cause pancreatic cancer and pancreatitis. In other ongoing work, Brown defends Pfizer in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. Together with Boston-based Matthew Holian, Brown also represents Bristol-Myers Squibb and Pfizer in an MDL involving claims that anticoagulant medication Eliquis causes bleeding. Bayer, Medtronic and Biogen are also clients of the firm. Cara Edwards in New York is another name to note and Boston-based Jessica Wilson was invited to partnership in January 2017.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to